Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;105(18):6649-6668.
doi: 10.1007/s00253-021-11539-w. Epub 2021 Sep 1.

Production of bioactive plant secondary metabolites through in vitro technologies-status and outlook

Affiliations
Review

Production of bioactive plant secondary metabolites through in vitro technologies-status and outlook

Christoph Wawrosch et al. Appl Microbiol Biotechnol. 2021 Sep.

Abstract

Medicinal plants have been used by mankind since ancient times, and many bioactive plant secondary metabolites are applied nowadays both directly as drugs, and as raw materials for semi-synthetic modifications. However, the structural complexity often thwarts cost-efficient chemical synthesis, and the usually low content in the native plant necessitates the processing of large amounts of field-cultivated raw material. The biotechnological manufacturing of such compounds offers a number of advantages like predictable, stable, and year-round sustainable production, scalability, and easier extraction and purification. Plant cell and tissue culture represents one possible alternative to the extraction of phytochemicals from plant material. Although a broad commercialization of such processes has not yet occurred, ongoing research indicates that plant in vitro systems such as cell suspension cultures, organ cultures, and transgenic hairy roots hold a promising potential as sources for bioactive compounds. Progress in the areas of biosynthetic pathway elucidation and genetic manipulation has expanded the possibilities to utilize plant metabolic engineering and heterologous production in microorganisms. This review aims to summarize recent advances in the in vitro production of high-value plant secondary metabolites of medicinal importance.Key points• Bioactive plant secondary metabolites are important for current and future use in medicine• In vitro production is a sustainable alternative to extraction from plants or costly chemical synthesis• Current research addresses plant cell and tissue culture, metabolic engineering, and heterologous production.

Keywords: Cell suspension; Hairy roots; Heterologous production; Plant secondary metabolites; Plant tissue culture.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chemical structures of some bioactive plant secondary metabolites used in medicine
Fig. 2
Fig. 2
Methods for the production of bioactive secondary metabolites through plant in vitro culture. A Establishment of in vitro cultures after surface sterilization of plant material. Callus formation can also be induced on material from organ cultures. Reversely, organs like roots or shoots can be regenerated from callus. Hairy roots are obtained by infection of sterilized donor plant, or in vitro cultivated material, with Agrobacterium rhizogenes. B Multiplication of primary callus/organs/roots, first selection, and establishment of liquid cultures. C Selection of high yielding lines and optimization of culture conditions (nutrient medium composition, inoculum density, temperature, light, agitation and aeration). Strategies like elicitation, precursor feeding, or immobilization are pursued to further improve productivity. D The bioreactor design will depend on the culture type: stirred tanks, but also airlift and bubble column reactors for cell suspensions; mist or spray reactors and temporary immersion systems for organ cultures (including hairy roots)

References

    1. Açıkgöz MA (2020) Establishment of cell suspension cultures of Ocimum basilicum L. and enhanced production of pharmaceutical active ingredients. Ind Crops Prod 148:112278. 10.1016/j.indcrop.2020.112278
    1. Adams AM, Kaplan NA, Wei Z, Brinton JD, Monnier CS, Enacopol AL, Ramelot TA, Jones JA. In vivo production of psilocybin in E. coli. Metab Eng. 2019;56:111–119. doi: 10.1016/j.ymben.2019.09.009. - DOI - PubMed
    1. Ahlawat S, Saxena P, Ali A, Khan S, Abdin MZ. Comparative study of withanolide production and the related transcriptional responses of biosynthetic genes in fungi elicited cell suspension culture of Withania somnifera in shake flask and bioreactor. Plant Physiol Biochem. 2017;114:19–28. doi: 10.1016/j.plaphy.2017.02.013. - DOI - PubMed
    1. Ahmad N, Rab A, Ahmad N, Fazal H. Differential pH-Induced Biosynthesis of Steviol Glycosides and Biochemical Parameters in Submerge Root Cultures of Stevia rebaudiana (Bert.) Sugar Tech. 2018;20:734–744. doi: 10.1007/s12355-018-0589-z. - DOI
    1. Ahmadi MK, Fang L, Moscatello N, Pfeifer BA. E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent. Metab Eng. 2016;38:382–388. doi: 10.1016/j.ymben.2016.10.001. - DOI - PubMed

LinkOut - more resources